Uncategorized

Targeting a molecule that helps cells repair their DNA could lead to a new treatment for some aggressive brain tumours, a University of Leeds study has found. Researchers discovered that switching off the RAD51 molecule increased the effectiveness of radiotherapy to kill glioblastoma cells in the lab. Glioblastomas are the most common type of brain tumour in adults. They are also the hardest to treat, with fewer than 5 in every 100 people surviving their disease for at least 5 years after diagnosis. The study, funded by Cancer Research UK, was published in the journal Stem Cell Reports. 

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-01-10-scientists-uncover-potential-brain-tumour-drug-target